When people hear about statins, they usually think about cholesterol. For decades, doctors have prescribed these medications to help lower cholesterol levels and reduce the risk of heart attacks and strokes.
But a major new study suggests that statins may have another important benefit that could help millions of older adults.
Researchers have found evidence that people who start taking statins may be less likely to develop frailty, a condition that often robs older adults of their strength, mobility, and independence.
Frailty is one of the biggest challenges facing aging populations. It is more than simply feeling older or moving more slowly. Frailty involves a combination of muscle weakness, exhaustion, slower movement, reduced physical activity, and a lower ability to recover from illness or injury.
A frail person may struggle with tasks that once seemed easy, such as climbing stairs, carrying groceries, or getting out of a chair. They are also more likely to be hospitalized after infections, falls, or other health problems. In severe cases, frailty can lead to disability, nursing home admission, and a lower quality of life.
Despite its importance, there are currently no approved medications specifically designed to prevent frailty. This has made it a major target for researchers interested in healthy aging.
A team from Mass General Brigham decided to investigate whether statins could help. Scientists have known for years that statins have effects beyond cholesterol reduction. In addition to improving cardiovascular health, these drugs can reduce inflammation, improve blood vessel function, and influence biological processes linked to aging.
To explore the relationship between statins and frailty, researchers analyzed healthcare records from the Veterans Affairs health system in the United States. The study included nearly one million veterans, making it one of the largest studies ever conducted on this topic.
The researchers followed 987,301 veterans who were at least 67 years old. At the start of the study, none of them were considered frail, and none were taking statin medications.
Over time, some participants began using statins while others did not. The researchers then tracked who developed frailty using a validated Veterans Affairs Frailty Index that evaluates multiple aspects of health and physical function.
The follow-up period lasted an average of 5.3 years. During that time, more than 636,000 veterans developed frailty, while nearly 291,000 participants started taking statins.
After taking into account many factors that can influence health outcomes, including smoking, body mass index, age, sex, race, cancer, diabetes, cardiovascular disease, and other medical conditions, the researchers discovered a significant difference.
People who started statin treatment had a 24% lower risk of becoming frail compared with those who did not take statins.
The protective association remained consistent across many different groups. It was seen among the oldest participants as well as among those with chronic illnesses such as arthritis, diabetes, dementia, and cardiovascular disease.
One especially interesting finding involved people who were already showing early signs of frailty. These individuals, sometimes called pre-frail, also appeared to benefit from statin use. This suggests that intervention may still be useful even after the earliest stages of physical decline have begun.
Researchers believe inflammation may be one of the key links between statins and frailty prevention. Scientists increasingly recognize that chronic inflammation contributes to many age-related conditions. Over time, inflammation may damage muscles, blood vessels, organs, and other tissues throughout the body.
Because statins reduce inflammation, they may help slow the biological processes that contribute to weakness and physical decline. This theory also helps explain why frailty and cardiovascular disease often occur together and share many risk factors.
The study’s senior author, Dr. Ariela Orkaby, noted that frailty and heart disease appear to involve similar underlying biological mechanisms. If those mechanisms can be targeted successfully, it may be possible to reduce the risk of both conditions simultaneously.
The research offers hope because statins are already widely available, relatively affordable, and familiar to doctors around the world. If future studies confirm these findings, healthcare providers may eventually have a practical tool for helping older adults remain active and independent for longer.
However, important questions remain. Because the study was observational, it cannot prove that statins directly caused the reduction in frailty risk.
People who take statins may differ in other ways that influence their health outcomes. Randomized clinical trials are still needed to determine whether statins truly prevent frailty and to identify the patients most likely to benefit.
In reviewing the evidence, this study stands out because of its enormous size, long follow-up period, and careful analysis of multiple health factors. The findings are biologically plausible because they fit with existing knowledge about inflammation, cardiovascular disease, and aging.
At the same time, the study remains an observational investigation rather than a clinical trial. Therefore, the results should be viewed as promising rather than conclusive.
Even so, the research provides strong support for further studies and raises the intriguing possibility that a medication developed to protect the heart could also help protect independence and quality of life during aging.
If you care about muscle, please read studies about factors that can cause muscle weakness in older people, and scientists find a way to reverse high blood sugar and muscle loss.
For more health information, please see recent studies about an easy, cheap way to maintain muscles, and results showing these vegetables essential for your muscle strength.
The study was published in the European Heart Journal.
Source: Mass General Brigham.
